title: Is fidaxomicin the drug of choice for treating Clostridium difficile-associated diarrhea in patients with cancer?
authors.affiliation: University of Arizona Cancer Center, Tucson, AZ.
authors.forename: Myke R
authors.initials: MR
authors.lastname: Green
authors.forename: Utkarsh H
authors.initials: UH
authors.lastname: Acharya
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Yeager
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D003967:Diarrhea / Q000382:microbiology*; D004761:Enterocolitis, Pseudomembranous / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D014640:Vancomycin